InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,520.07
(
-0.16%
)
US TECH 100
18,416.00
(
-0.05%
)
Dow Jones
40,974.97
(
0.09%
)
Brent Oil
73.22
(
0.78%
)
Bitcoin
56,652.72
(
-2.27%
)
Post# of 656390
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LexTrader

Send PM Follow Ignore
Followers 241
Posts 21227
Boards Moderated 0
Alias Born 08/10/2000

LexTrader

Member Level

Re: None

Monday, 05/03/2021 7:32:10 AM

Monday, May 03, 2021 7:32:10 AM

Post# of 656390
GNFT news: 07:30 AM EDT, 05/03/2021 (MT Newswires) -- Genfit (GNFT) said Monday its partner Labcorp (LH) has launched NASHnext, a non-invasive test for nonalcoholic steatohepatitis, in the US and Canada.
In September 2020, Genfit entered into a licensing agreement with Labcorp for the development and commercialization of a blood-based molecular diagnostic test powered by Genfit's technology.
Genfit shares were up nearly 6% in premarket trading, while Labcorp was flat.
Price: 4.5500, Change: +0.25, Percent Change: +5.81
http://www.mtnewswires.com Copyright © 2021 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up